Precigen Inc (PGEN)
1.28
-0.01
(-0.78%)
USD |
NASDAQ |
May 10, 16:00
1.28
0.00 (0.00%)
After-Hours: 19:03
Precigen Total Liabilities (Quarterly): 32.54M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.54M |
| September 30, 2023 | 43.01M |
| June 30, 2023 | 41.32M |
| March 31, 2023 | 57.41M |
| December 31, 2022 | 89.72M |
| September 30, 2022 | 116.71M |
| June 30, 2022 | 265.57M |
| March 31, 2022 | 261.73M |
| December 31, 2021 | 252.51M |
| September 30, 2021 | 245.65M |
| June 30, 2021 | 243.38M |
| March 31, 2021 | 232.19M |
| December 31, 2020 | 247.41M |
| September 30, 2020 | 277.63M |
| June 30, 2020 | 312.17M |
| March 31, 2020 | 317.44M |
| December 31, 2019 | 384.05M |
| September 30, 2019 | 376.48M |
| June 30, 2019 | 375.96M |
| March 31, 2019 | 375.04M |
| December 31, 2018 | 337.46M |
| September 30, 2018 | 424.97M |
| June 30, 2018 | 258.01M |
| Date | Value |
|---|---|
| March 31, 2018 | 324.24M |
| December 31, 2017 | 300.31M |
| September 30, 2017 | 345.08M |
| June 30, 2017 | 362.44M |
| March 31, 2017 | 365.77M |
| December 31, 2016 | 379.82M |
| September 30, 2016 | 397.17M |
| June 30, 2016 | 402.93M |
| March 31, 2016 | 287.60M |
| December 31, 2015 | 277.16M |
| September 30, 2015 | 260.26M |
| June 30, 2015 | 306.01M |
| March 31, 2015 | 166.64M |
| December 31, 2014 | 166.98M |
| September 30, 2014 | 158.66M |
| June 30, 2014 | 112.17M |
| March 31, 2014 | 115.91M |
| December 31, 2013 | 88.13M |
| September 30, 2013 | 82.99M |
| June 30, 2013 | 644.98M |
| March 31, 2013 | 71.94M |
| December 31, 2012 | 473.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
32.54M
Minimum
Dec 2023
384.05M
Maximum
Dec 2019
219.63M
Average
247.41M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.198M |
| HealthEquity Inc | 1.129B |
| Corvus Pharmaceuticals Inc | 6.869M |
| Oragenics Inc | 1.798M |
| MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 151.04M |
| Shareholders Equity (Quarterly) | 118.50M |
| Current Ratio | 2.991 |
| Net Debt Paydown Yield | 4.92% |